Literature DB >> 16897227

Sensitivity and specificity of new eye check chart for neuro-ophthalmological diseases.

Hideki Murai1, Motohiro Kiyosawa2, Manabu Mochizuki1, Taketoshi Suzuki3.   

Abstract

PURPOSE: To determine the sensitivity and specificity of a new Eye Check Chart (ECC) for screening neuro-ophthalmological patients with lesions in the visual pathways.
METHODS: The Humphrey perimeter (HP) with the 30-2 SITA Fast program was used to confirm the visual field defects found in 65 eyes of 35 neuro-ophthalmological patients. Forty eyes had pregeniculate lesions, and 25 eyes had postgeniculate lesions. As controls, 22 eyes of 12 patients without visual field defects were also examined. All subjects were then examined using the eye check chart (ECC) to determine whether comparable visual field defects were detected. The eyes were separated into those in which the ECC findings agreed with the HP findings, and those in which they did not agree. Based on HP results, the sensitivity and specificity of the ECC results were calculated.
RESULTS: The sensitivity of ECC was 87% in patients with pregeniculate lesions and 80% in patients with postgeniculate lesions. The overall specificity of ECC was 91%.
CONCLUSION: This high sensitivity and specificity indicate that ECC can give reliable results in screening neuro-ophthalmological patients for lesions in the visual pathways. Copyright (c) Japanese Ophthalmological Society 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16897227     DOI: 10.1007/s10384-006-0329-x

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  Red colour comparison perimetry chart in neuro-ophthalmological examination.

Authors:  E Mutlukan; J F Cullen
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

2.  The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.